Frontera, a pioneer in AI-enabled autism care, has announced the expansion of its services across New Mexico and the launch of FronteraCare, a clinician-led network aimed at improving health equity for underserved communities. The initiative, announced on September 12, 2025, addresses long-standing barriers in autism diagnosis and treatment by reducing wait times and enhancing access in rural areas.
FronteraCare Launch: New clinician-led network for autism care in New Mexico.
Service Expansion: Covers Santa Fe, Espanola, Las Cruces, Pueblo, Roswell, Hobbs, Alamogordo, Clovis, Santa Teresa, and Hatch.
AI-Powered Diagnostics: Reduces wait times for autism diagnosis and treatment.
Focus: Health equity for rural and underserved communities.
Leadership: Co-founded by Amol Deshpande and Jeff Flores (CEO, MECA Therapies).
Backers: Lux Capital, Lightspeed Venture Partners, Inspired Capital, Menlo Ventures.
Autism care in New Mexico, particularly in rural areas, has been hindered by long waitlists, fragmented services, and limited providers, leading to delays in diagnosis and treatment that impact children’s long-term development. FronteraCare, launched in 2023 by Amol Deshpande and Jeff Flores, combines AI-powered tools with culturally informed care to address these challenges. “For decades, I’ve seen families wait too long for autism diagnosis and treatment,” said Flores, Co-Founder of Frontera and CEO of MECA Therapies. “Frontera’s technology solves real problems for New Mexico communities.”
FronteraCare’s expansion targets communities across Santa Fe, Espanola, Las Cruces, and beyond, reducing travel burdens and increasing clinician capacity. By leveraging AI, the platform streamlines diagnostics and treatment processes, significantly cutting wait times. “Every child throughout New Mexico deserves timely access to care, and FronteraCare will help make that possible,” said Deshpande, a parent to a son with autism. Since its initial launch, Frontera has demonstrated benefits like faster care delivery and improved access for local families.
Frontera’s mission is to use AI to facilitate health equity, ensuring timely and affordable autism care. Its technology empowers clinicians to diagnose and treat autism more efficiently, addressing systemic gaps in underserved regions. Backed by investors like Lux Capital and Lightspeed Venture Partners, Frontera is scaling its clinician-led network to transform autism care delivery.
Frontera transforms autism care in underserved communities with AI-powered tools that enhance clinicians’ ability to diagnose and treat autism and related disorders. By reducing time to care and increasing accessibility, Frontera supports families in need.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.